RO100758B1 - Procedeu de obtinere a unui ser anti-hbs - Google Patents

Procedeu de obtinere a unui ser anti-hbs

Info

Publication number
RO100758B1
RO100758B1 RO132540A RO13254088A RO100758B1 RO 100758 B1 RO100758 B1 RO 100758B1 RO 132540 A RO132540 A RO 132540A RO 13254088 A RO13254088 A RO 13254088A RO 100758 B1 RO100758 B1 RO 100758B1
Authority
RO
Romania
Prior art keywords
hbs
volumes
antigen
partially purified
days
Prior art date
Application number
RO132540A
Other languages
English (en)
Other versions
RO100758A2 (ro
Inventor
Constantin Popovici
Vasile Popa
Nicolae Tivga
Carola Nicolescu
Emilia Sima
Original Assignee
Constantin Popovici
Vasile Popa
Nicolae Tivga
Carola Nicolescu
Emilia Sima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Constantin Popovici, Vasile Popa, Nicolae Tivga, Carola Nicolescu, Emilia Sima filed Critical Constantin Popovici
Priority to RO1988132540A priority Critical patent/RO100758A2/ro
Publication of RO100758B1 publication Critical patent/RO100758B1/ro
Publication of RO100758A2 publication Critical patent/RO100758A2/ro

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Procedeul, conform inventiei, consta în aceea ca se imunizeaza calul, pe cale intradermica cu un amestec compus din 3 volume antigen Hbs partial purificat cu titru 1/64 si 3 volume adjuvant Freund complet, dupa 30 zile se administreaza pe cale intramusculara 5 volume antigen partial purificat cu acelasi titru iar dupa alte 30 de zile se administreaza intramuscular 10 vol. Antigen Hbs partial purificat, în continuare dupa 7, 14 si 16 zile de la ultima inoculare se face sîngerarea de proba si de productie, serul obtinut este absorbit cu un volum egal de ser uman care contine anticorpi anti Hbs si are un titru de maximum 1/2.
RO1988132540A 1988-03-10 1988-03-10 Procedeu de obtinere a unui ser anti-hbs RO100758A2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO1988132540A RO100758A2 (ro) 1988-03-10 1988-03-10 Procedeu de obtinere a unui ser anti-hbs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO1988132540A RO100758A2 (ro) 1988-03-10 1988-03-10 Procedeu de obtinere a unui ser anti-hbs

Publications (2)

Publication Number Publication Date
RO100758B1 true RO100758B1 (ro) 1991-03-01
RO100758A2 RO100758A2 (ro) 1991-11-12

Family

ID=20121274

Family Applications (1)

Application Number Title Priority Date Filing Date
RO1988132540A RO100758A2 (ro) 1988-03-10 1988-03-10 Procedeu de obtinere a unui ser anti-hbs

Country Status (1)

Country Link
RO (1) RO100758A2 (ro)

Also Published As

Publication number Publication date
RO100758A2 (ro) 1991-11-12

Similar Documents

Publication Publication Date Title
Bazaral et al. Standardization and stability of immunoglobulin E (IgE)
Pernis et al. Adjuvant effect of silica (tridymite) on antibody production.
NO913428D0 (no) Humant intra-acrosomalt sperma-antigen for anvendelse i en befruktningshindrende vaksine.
LU91610I2 (fr) Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
ES2054696T3 (es) Agente viral de la hepatitis nanb, antigen y reactivo inmunologico.
Mejri et al. Th2 polarization of the immune response of BALB/c mice to Ixodes ricinus instars, importance of several antigens in activation of specific Th2 subpopulations
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
Baumal et al. Synthesis, Assembly and Secretion of γ-Globulin by Mouse Myeloma Cells: V. Balanced and Unbalanced Synthesis of Heavy and Light Chains by IgG-Producing Tumors and Cell Lines
Graham et al. Complement-requiring neutralizing antibodies in hyperimmune sera to human cytomegaloviruses
DE3584872D1 (de) Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag.
Hinuma et al. Studies on the Complement-Fixing Antigens of Poliomyelitis: III. Intracellular Development of Antigen
Adinolfi et al. Human complement C7 and C9 in fetal and newborn sera.
RO100758B1 (ro) Procedeu de obtinere a unui ser anti-hbs
Teramoto et al. Radioimmunoassays that demonstrate type-specific and group-specific antigenic reactivities for the major internal structural protein of murine mammary tumor viruses
FI874273L (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
EP0229492A3 (en) A human antigen designated gp650 in substantially purified form
Kerttula et al. Immunity to diphtheria in Helsinki in 1975
ATE4282T1 (de) Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen.
ATE18007T1 (de) Hepatitisimpfstoff.
de Saint Martin et al. Titration of antibodies to tetanus toxoid by agglutination of purified tetanus toxoid sensitized latex particles
Thiel et al. Isolation of the Major Glycoprotein (gp70) of Simian Sarcoma Virus (SSV-1/SSAV-1) in Preparative Quantities
RU2183972C2 (ru) Способ получения высокоактивной специфической к вирусу классической чумы свиней сыворотки крови свиней
Boucher et al. A sensitive neutralization test for the adeno-associated satellite viruses
SU974651A1 (ru) Способ получени иммунной сыворотки к вирусу клещевого энцефалита